EXAC - Exactech, Inc.
| Previous Close | N/A |
| Open | N/A |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | N/A - N/A |
| 52 Week Range | undefined - undefined |
| Volume | N/A |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.•8 months ago
With A -96.98% Earnings Drop Lately, Did Exactech Inc (NASDAQ:EXAC) Underperform Its Industry?
Investors with a long-term horizong may find it valuable to assess Exactech Inc’s (NASDAQ:EXAC) earnings trend over time and against its industry benchmark as opposed to simply looking at aRead More...
- Zacks•8 months ago
Exactech (EXAC) Gets Acquired by TPG Capital, Goes Private
TPG Capital acquires Exactech (EXAC) with a view to cash in on its resources and gain a foothold in the orthopedics market.
- Business Wire•8 months ago
Exactech Announces Completion of Merger with TPG Capital
Exactech, Inc. , a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, is pleased to announce the successful completion of the previously announced merger agreement with TPG Capital, pursuant to which TPG has acquired all of the issued and outstanding common stock of Exactech.
- Business Wire•8 months ago
Exactech Shareholders Approve Merger Agreement with TPG Capital
Exactech , a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that at a Special Meeting of Shareholders held earlier today, Exactech’s shareholders approved the previously announced merger agreement with TPG Capital and certain of its affiliates, and approved the other two proposals described in Exactech’s proxy ...
- Moody's•9 months ago
Osteon Merger Sub, Inc. -- Moody's assigns B2 Corporate Family Rating to acquirer of Exactech
Moody's Investors Service, ("Moody's") assigned a B2 Corporate Family Rating and a B2-PD Probability of Default Rating to Osteon Merger Sub, Inc. ("Osteon"). Moody's also assigned a ...
- ACCESSWIRE•10 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders - EXAC
NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Exactech, Inc. ("Exactech" or the "Company") ...
- Business Wire•10 months ago
EXACTECH (EXAC) INVESTOR ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Exactech, Inc.
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Exactech, Inc.
- ACCESSWIRE•10 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders - EXAC
NEW YORK, NY / ACCESSWIRE / December 15, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Exactech, Inc. ("Exactech" or the "Company") ...
- PR Newswire•10 months ago
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Exactech, Inc. (EXAC)
NEW YORK , Dec. 15, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Exactech, Inc. ("Exactech ...
- Business Wire•10 months ago
EXACTECH (EXAC) SHAREHOLDER ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Exactech, Inc.
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Exactech, Inc.
- Business Wire•10 months ago
Exactech Announces Successful First Surgery with Vantage ® Total Ankle Mobile Bearing System
Exactech, Inc. , a developer and producer of bone and joint restoration products for extremities, hip, and knee, announced today the successful first surgery using its new Vantage® Total Ankle Mobile Bearing System, the newest addition to the Exactech extremities product line.
- Reuters•10 months ago
UPDATE 2-Exactech gets higher $737 mln cash offer from TPG Capital
Medical device maker Exactech Inc said on Monday TPG Capital raised its offer to buy the company to $737 million cash and its board agreed to the amended terms, saying the offer was in the best interests of shareholders. Exactech expects the deal to close during the first quarter of 2018. By going private, Exactech would escape the quarter-to-quarter scrutiny of the public markets.
- Reuters•10 months ago
Deals of the day- Mergers and acquisitions
** Medical device maker Exactech Inc said TPG Capital raised its offer to buy the company to $737 million cash and its board agreed to the amended terms, saying the offer was in the best interests of shareholders. ** Insurer Hartford Financial Services Group said it would sell its Talcott Resolution unit in a deal valued at $2.05 billion, completing its exit from the life and annuity business.
- ACCESSWIRE•10 months ago
ACT NOW: Monteverde & Associates PC Announces An Investigation Of Exactech, Inc. - EXAC
NEW YORK, NY / ACCESSWIRE / December 4, 2017 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New ...
- Business Wire•10 months ago
Exactech and TPG Capital Announce Amended Merger Agreement Providing for Increase in Merger Consideration to $49.25 per share
Exactech, Inc. , a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, announced today that it has entered into an amendment to its merger agreement with TPG Capital and certain of its affiliates which was previously announced on October 23, 2017.
- Business Wire•last year
Exactech Announces Successful First Revision Knee Replacement Surgery with Truliant® Instrumentation
Exactech , a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, is pleased to announce that the first revision knee surgery was performed using the company's award-winning Truliant® instrumentation.
- Business Wire•last year
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Exactech, Inc. and Encourages Shareholders to Contact the Firm for Additional Information
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Exactech, Inc.
- ACCESSWIRE•last year
Exactech, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / October 31, 2017 / Exactech, Inc. (NASDAQ: EXAC ) will be discussing their earnings results in their Q3 Earnings Call to be held on October 31, 2017 at 10:00 AM Eastern Time. ...
- Associated Press•last year
Exactech posts 3Q profit
On a per-share basis, the Gainsville, Florida-based company said it had net income of 20 cents. The maker of bone and joint restoration products posted revenue of $61.4 million in the period. Exactech ...
